Overview
Ashwin Chandar is a Hematologist Oncology specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Chandar is rated as an Experienced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Acute Mountain Sickness, Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, and Multiple Myeloma.
His clinical research consists of co-authoring 6 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Hemolytic Anemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
111 S 11th St, Philadelphia, PA 19107
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Jefferson University Physicians
Sophie Lanzkron is a Hematologist in Philadelphia, Pennsylvania. Dr. Lanzkron is rated as an Elite provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Hemoglobinopathy, Congenital Hemolytic Anemia, and Hemolytic Anemia. Dr. Lanzkron is currently accepting new patients.
Farzana Sayani is a Hematologist and a Hematologist Oncology provider in Philadelphia, Pennsylvania. Dr. Sayani is rated as a Distinguished provider by MediFind in the treatment of Hemolytic Anemia. Her top areas of expertise are Sickle Cell Disease, Thalassemia, Beta Thalassemia, and Hemoglobin SC Disease.
Inspira Health Network Medical Group PC
Joseph Tropea is a Hematologist Oncology specialist and an Oncologist in Pittsgrove, New Jersey. Dr. Tropea is rated as an Advanced provider by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Childhood Iron Deficiency Anemia, Anemia, Iron Deficiency Anemia, and Congenital Hemolytic Anemia.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Mountain SicknessDr. Chandar isAdvanced. Learn about Acute Mountain Sickness.
- AnemiaDr. Chandar isAdvanced. Learn about Anemia.
- Childhood Acute Myeloid LeukemiaDr. Chandar isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Childhood Iron Deficiency AnemiaDr. Chandar isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- Chronic Myelogenous Leukemia (CML)Dr. Chandar isAdvanced. Learn about Chronic Myelogenous Leukemia (CML).
- Febrile NeutropeniaDr. Chandar isAdvanced. Learn about Febrile Neutropenia.
- Experienced
- Acute Arterial Occlusion of KidneyDr. Chandar isExperienced. Learn about Acute Arterial Occlusion of Kidney.
- Adult Immune ThrombocytopeniaDr. Chandar isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Chandar isExperienced. Learn about Agranulocytosis.
- Alpha ThalassemiaDr. Chandar isExperienced. Learn about Alpha Thalassemia.
- Alpha Thalassemia X-Linked Intellectual Disability Syndrome
- Antiphospholipid SyndromeDr. Chandar isExperienced. Learn about Antiphospholipid Syndrome.